ArticleNature communications2023
Ultra-short pulse laser acceleration of protons to 80 MeV from cryogenic hydrogen jets tailored to near-critical density.
Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Transition Radiation Field Enhanced Laser Proton Acceleration Employing Near-Critical-Density Foam.Nature communications · 2026Article
- Single-event fast neutron time-of-flight spectrometry with a petawatt-laser-driven neutron source.Nature communications · 2026Article
- Multi-PW laser-driven proton acceleration using a plasma-lens target.Scientific reports · 2025Article
- Highly ordered vertical nickel nanotubes and nanowires on thin substrate for high power lasers experiments.Discover nano · 2025Article
- Theoretical and experimental study of second order dynamic effects in nanocomposite thin film thermocouples affected by substrate roughness.Scientific reports · 2025Article
- Laser-driven proton sources for efficient radiation testing.Scientific reports · 2025Article
- Advanced laser pulse metrology through 2D self-referenced spectral interferometry.Scientific reports · 2025Article
- Laser-driven proton acceleration beyond 100 MeV by radiation pressure and Coulomb repulsion in a conduction-restricted plasma.Nature communications · 2025Article
- Optical probing of ultrafast laser-induced solid-to-overdense-plasma transitions.Light, science & applications · 2024Article
- Undepleted direct laser acceleration.Science advances · 2024Article
- Ultra-short pulse laser acceleration of protons to 80 MeV from cryogenic hydrogen jets tailored to near-critical density.Nature communications · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors.
Funding
Abstract
Laser plasma-based particle accelerators attract great interest in fields where conventional accelerators reach limits based on size, cost or beam parameters. Despite the fact that particle in cell simulations have predicted several advantageous ion acceleration schemes, laser accelerators have not yet reached their full potential in producing simultaneous high-radiation doses at high particle energies. The most stringent limitation is the lack of a suitable high-repetition rate target that also provides a high degree of control of the plasma conditions required to access these advanced regimes. Here, we demonstrate that the interaction of petawatt-class laser pulses with a pre-formed micrometer-sized cryogenic hydrogen jet plasma overcomes these limitations enabling tailored density scans from the solid to the underdense regime. Our proof-of-concept experiment demonstrates that the near-critical plasma density profile produces proton energies of up to 80 MeV. Based on hydrodynamic and three-dimensional particle in cell simulations, transition between different acceleration schemes are shown, suggesting enhanced proton acceleration at the relativistic transparency front for the optimal case.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.